Post-earnings recap
Reported
Thu, Aug 3, 2023
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
Est. EPS
—
Est. Rev
—
Impl. Move
—
Collegium Pharmaceutical reported an EPS of $0.34, which was significantly below expectations, resulting in a surprise of -69.31%. Despite this miss, the stock saw a slight increase of 0.09%, indicating that investors may have had lower expectations or are reacting to other factors not captured in the earnings report.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.34 | N/A | -69.31% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.